8-K
Tevogen Inc. Announces Resignation of Director Susan Podlogar and Board Size Reduction
8-K
Tevogen Inc. Amends Loan Agreement with The Patel Family, LLP and Grants 50M Restricted Stock Award to CEO
8-K
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
8-K
Tevogen Inc. Grants Restricted Stock Awards to Executive Officers Contingent on Revenue Milestone
8-K
Tevogen Inc. Regains Compliance with Nasdaq Minimum Market Value Requirement
8-K
Tevogen Inc. Announces Results of Annual Meeting and Approval of Plan Amendment
